Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

被引：3
|
作者：
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol Nucl Med & Mol Imaging, Groningen, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 04期
关键词：
FDG-PET; Hodgkin lymphoma; POSITRON-EMISSION-TOMOGRAPHY;
D O I：
10.1111/bjh.15602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 760
页数：3
相关论文
共 50 条
  • [21] Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Feldman, T.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Whole-slide image analysis of the tumor as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP
    Jachimowicz, Ron Daniel
    Pieper, Luise
    Reinke, Sarah
    Gontarewicz, Artur
    Pluetschow, Annette
    Haverkamp, Heinz
    Frauenfeld, Leonie
    Fend, Falko
    Overkamp, Mathis
    Jochims, Franziska
    Thorns, Christoph
    Hansmann, Martin Leo
    Moller, Peter
    Rosenwald, Andreas
    Stein, Harald
    Reinhardt, Hans Christian
    Borchmann, Peter
    von Tresckow, Bastian
    Engert, Andreas
    Klapper, Wolfram
    HAEMATOLOGICA, 2021, 106 (06) : 1684 - 1692
  • [23] eAssessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
    Kobe, C.
    Markova, J.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Pluetschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 252 - 253
  • [24] Assessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
    Kobe, C.
    Markova, J.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Pluetschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S252 - S253
  • [25] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee
    Dann, Eldad J.
    Paltiel, Ora
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 131 - 133
  • [26] TAILORED THERAPY FOR ADVANCED-STAGE HODGKIN LYMPHOMA, GUIDED BY INTERIM 18FDG-PET, WITH BEACOPP-ESCALATED FOLLOWED BY ABVD REGIMEN DECREASES REFRACTORY DISEASE RATES
    Amutio, E.
    Del Orbe, R. A.
    Amarika, I.
    Landeta, E.
    Zamora, M. E.
    Puente, M.
    Iglesias-Perez, A. M.
    Olazabal, I.
    Duenas, M.
    Balerdi, A.
    Elicegui, L.
    Arambarri, S.
    Garcia-Ruiz, J. C.
    HAEMATOLOGICA, 2014, 99 : 676 - 677
  • [27] Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)
    Kusumoto, Shigeru
    Munakata, Wataru
    Machida, Ryunosuke
    Terauchi, Takashi
    Onaya, Hiroaki
    Oguchi, Masahiko
    Iida, Shinsuke
    Nosaka, Kisato
    Suzuki, Yasuhiro
    Harada, Yasuhiko
    Miyazaki, Kana
    Maruta, Masaki
    Fukuhara, Noriko
    Toubai, Tomomi
    Kubota, Nobuko
    Ohmachi, Ken
    Saito, Toko
    Rai, Shinya
    Mizuno, Ishikazu
    Fukuhara, Suguru
    Takeuchi, Mai
    Tateishi, Ukihide
    Maruyama, Dai
    Tsukasaki, Kunihiro
    Nagai, Hirokazu
    CANCER SCIENCE, 2024, 115 (10) : 3384 - 3393
  • [28] Spermatogenesis in advanced-stage Hodgkin's lymphoma patients treated with escalated BEACOPP: a retrospective study of impaired fertility and recovery
    Williams, E.
    Jayadev, V.
    HUMAN REPRODUCTION, 2020, 35 : 167 - 167
  • [29] The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established
    Adams, H. J. A.
    Kwee, T. C.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 510 - 512
  • [30] Cost-Effectiveness of Interim PET Response Adapted Therapy In ABVD-Treated, Advanced-Stage Hodgkin Lymphoma
    Gallamini, Andrea
    Marchetti, Monia
    Borra, Anna
    Sorasio, Roberto
    Fiore, Francesca
    BLOOD, 2011, 118 (21) : 679 - 680
12345